EISENBERG JEFFREY F 4

4 · MABVAX THERAPEUTICS HOLDINGS, INC. · Filed Feb 23, 2018

Insider Transaction Report

Form 4
Period: 2018-02-21
Transactions
  • Award

    Option to Purchase Common Stock

    2018-02-21+35,00035,000 total
    Exercise: $2.04Exp: 2028-02-21Common Stock (35,000 underlying)
Footnotes (2)
  • [F1]Option award is partial compensation for service as a director.
  • [F2]The Option Shares shall vest on a monthly basis after the commencement date until fully vested on the one year anniversary of the commencement date.

Documents

1 file
  • 4
    form4-02232018_120235.xmlPrimary